Growth Hormone Secretagogues · Research deep dive
CJC-1295: the cited literature
Every study referenced in the CJC-1295 monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, CJC-1295 is studied at 100 mcg – 300 mcg per administration, typically once or twice daily (no-dac). The reference walkthrough below maps each citation to what it actually showed.
References covered
Prolonged stimulation of GH and IGF-1 by CJC-1295
J. Clin. Endocrinol. Metab., 2006
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for CJC-1295.